These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 7959358

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A comparison of the antithrombotic effects of heparin and of low molecular weight heparins with increasing antifactor Xa/antifactor IIa ratio in the rabbit.
    Carrie D, Caranobe C, Boneu B.
    Br J Haematol; 1993 Apr; 83(4):622-6. PubMed ID: 8390849
    [Abstract] [Full Text] [Related]

  • 5. Mode of action of unfractionated and low molecular weight heparins on the generation of thrombin in plasma.
    Hemker HC, Béguin S.
    Haemostasis; 1990 Apr; 20 Suppl 1():81-92. PubMed ID: 1964667
    [Abstract] [Full Text] [Related]

  • 6. Determination of the levels of unfractionated and low-molecular-weight heparins in plasma: their effect on thrombin-mediated feedback reactions in vivo. Preliminary results after subcutaneous injection.
    Hemker HC, Béguin S, Bendetowicz AV, Wielders S.
    Haemostasis; 1991 Apr; 21(4):258-72. PubMed ID: 1665467
    [Abstract] [Full Text] [Related]

  • 7. Treatment with LMWHs inhibits factor VIIa generation during in vitro coagulation of whole blood.
    Gerotziafas GT, Bara L, Bloch MF, Makris PE, Samama MM.
    Thromb Res; 1996 Feb 15; 81(4):491-6. PubMed ID: 8907299
    [Abstract] [Full Text] [Related]

  • 8. [Therapeutic indications of low molecular weight heparins].
    Samama MM, Michaut-Paterno F.
    Arch Mal Coeur Vaiss; 1991 Nov 15; 84(11 Suppl):1733-43. PubMed ID: 1662941
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effect of protamine sulphate on plasma tissue factor pathway inhibitor released by intravenous and subcutaneous unfractionated and low molecular weight heparin in man.
    Holst J, Lindblad B, Bergqvist D, Hedner U, Nordfang O, Ostergaard P.
    Thromb Res; 1997 May 15; 86(4):343-8. PubMed ID: 9187023
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The role of tissue factor pathway inhibitor in the mediation of the antithrombotic actions of heparin and low-molecular-weight heparin.
    Hoppensteadt DA, Jeske W, Fareed J, Bermes EW.
    Blood Coagul Fibrinolysis; 1995 Jun 15; 6 Suppl 1():S57-64. PubMed ID: 7647223
    [Abstract] [Full Text] [Related]

  • 15. Dermatan sulfate is a more potent inhibitor of clot-bound thrombin than unfractionated and low molecular weight heparins.
    Bendayan P, Boccalon H, Dupouy D, Boneu B.
    Thromb Haemost; 1994 May 15; 71(5):576-80. PubMed ID: 8091383
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Low molecular weight heparins prevent thrombin-induced thrombo-embolism in mice despite low anti-thrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition.
    Momi S, Nasimi M, Colucci M, Nenci GG, Gresele P.
    Haematologica; 2001 Mar 15; 86(3):297-302. PubMed ID: 11255277
    [Abstract] [Full Text] [Related]

  • 18. The inhibition of intrinsic prothrombinase and its generation by heparin and four derivatives in prothrombin poor plasma.
    Bendetowicz AV, Bara L, Samama MM.
    Thromb Res; 1990 Jun 01; 58(5):445-54. PubMed ID: 2164262
    [Abstract] [Full Text] [Related]

  • 19. Comparative effects of synthetic pentasaccharide, low-molecular-weight heparin, unfractionated heparin and recombinant hirudin on the generation of factor VIIa and prothrombin activation after coagulation of human plasma.
    Gerotziafas GT, Bara L, Bloch MF, Makris PE, Samama MM.
    Blood Coagul Fibrinolysis; 1998 Oct 01; 9(7):571-80. PubMed ID: 9863704
    [Abstract] [Full Text] [Related]

  • 20. Antithrombotic potencies of heparins in relation to their antifactor Xa and antithrombin activities: an experimental study in two models of thrombosis in the rabbit.
    Amar J, Caranobe C, Sie P, Boneu B.
    Br J Haematol; 1990 Sep 01; 76(1):94-100. PubMed ID: 2223652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.